Sign in
4

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001127602-25-006123

Chief Commercial Officer acquired 246.16 shares (option exercise)

  • Chief Commercial Officer gave up 83.18 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reiss-Clark Cindy Chief Commercial Officer 2025-02-18 Option exercise +246.16 $211.00 $51,940 5,130.51 D
Reiss-Clark Cindy Chief Commercial Officer 2025-02-18 Shares withheld for taxes −83.18 $211.00 $17,551 5,047.33 D
Derivatives
Reiss-Clark Cindy Chief Commercial Officer 2025-02-18 Grant or award · Stock Option (Right to Buy) +1,162 1,162 D
Reiss-Clark Cindy Chief Commercial Officer 2025-02-18 Grant or award · Rst. Stock Unit +503 503 D
Loading xslF345X05/form4.xml…